| Line Item | 2025-02-01 | Y/Y |
|---|---|---|
| Revenue | $5.77B | +4.7% |
| Cost of Revenue | $3.39B | +5.3% |
| Gross Profit | $2.38B | +3.9% |
| R&D Expense | $1.95B | +2.9% |
| SG&A Expense | $798.2M | -4.3% |
| Operating Income | -$720.3M | -26.9% |
| Interest Expense | $183.0M | -13.6% |
| Pre-tax Income | -$894.7M | -17.9% |
| Income Tax | -$9.7M |
| Line Item | 2025-02-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $948.3M | -0.3% |
| Accounts Receivable | $1.03B | -8.3% |
| Inventory | $1.03B | +19.1% |
| Current Assets | $3.12B | +1.9% |
| Total Assets | $20.20B | -4.8% |
| Current Liabilities | $2.03B | +11.7% |
| Long-term Debt | $4.06B | -2.5% |
| Line Item | 2025-02-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.68B | +22.7% |
| Capital Expenditures | $284.6M | -15.4% |
| Investing Cash Flow | -$300.7M | +14.2% |
| Financing Cash Flow | -$1.38B | -41.1% |
| Free Cash Flow | $1.40B | +35.0% |
| -105.6% |
| Net Income | -$885.0M | +5.2% |
| EPS (Basic) | -$1.02 | +5.6% |
| EPS (Diluted) | -$1.02 | +5.6% |
| Total Liabilities |
| $6.78B |
| +5.9% |
| Stockholders' Equity | $13.43B | -9.5% |